Info-congres. Optimalisation de la prise en charge du patient diabetique: une selection de quelques essais cliniques presentes au Congres 2004 de l'American Diabetes Association.
[en] The 64th scientific congress of the American Diabetes Association had a special session devoted to the presentation of the results from three clinical trials: 1) the first multicentre international trial of pancreatic islet transplantation according to the so-called Edmonton protocol with the primary endpoint of restoring insulin independence in type 1 diabetic patients; 2) three pivotal studies of 30 weeks testing both the efficacy and safety of exenatide (exendin-4), a new insulin secretagogue that is a long-acting analogue of glucagon-like peptide-1, in patients with type 2 diabetes treated with either metformin, or a sulfonylurea, or a metformin-sulfonylurea combination; and 3) the "Collaborative AtoRvastatin Diabetes Study" (CARDS), a placebo-controlled primary prevention trial of cardiovascular complications using atorvastatin 10 mg in 2 838 at risk patients with type 2 diabetes. The main results and conclusions of these trials are briefly presented as they open new perspectives in the management of patients with type 1 or type 2 diabetes mellitus.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Radermecker, Régis ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Philips, Jean-Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Language :
French
Title :
Info-congres. Optimalisation de la prise en charge du patient diabetique: une selection de quelques essais cliniques presentes au Congres 2004 de l'American Diabetes Association.
Alternative titles :
[en] Optimizing the managment of patients with diabetes mellitus: selected clinical trials from the 2004 Congress of the American Diabetes Association
Publication date :
2004
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Scheen, A.J., Evidence-based medicine. Apport des essais cliniques contrô lés (2000) Rev Med Liège, 55, pp. 216-219
Shapiro, J.A.M., Lakey, J.R.T., Ryan, E.A., Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen (2000) N Engl J Med, 343, pp. 230-238
Scheen, A.J., Insulino-indépendance prolongée après transplantation d'îlots de Langerhans chez le patient diabétique de type 1: L'aboutissement d'un rêve? (2000) Rev Med Liège, 55, pp. 803-805
Shapiro, J., Ricordi, C., Hering, B., International multi-center trial of islet transplantation using the Edmonton Protocol in patients with type 1 diabetes (2004) Diabetes, 53 (SUPPL. 2), pp. A455
Scheen, A.J., Pathophysiology of type 2 diabetes (2003) Acta Clin Belg, 58, pp. 335-341
Holst, J.J., Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1 (2002) Diabetes/Metab Res Rev, 18, pp. 430-441
Buse, J., Henry, R., Han, J., Effect of exenatide (exendin-4) on glycemic control and safety over 30 weeks in sulfonylurea-treated patients with type 2 diabetes (2004) Diabetes, 53 (SUPPL. 2), pp. A82
Kendall, D.M., Riddle, M.C., Zhuang, D., Effects of exenatide (exendin-4) on glycemic control and weight in patients with type 2 diabetes treated with metformin and a sulfonylurea (2004) 64th American Diabetes Association Congress, , Late-breaking abstract presented, Orlando, June 4-8
De Fronzo, R., Ratner, R., Han, J., Effects of exenatide (synthetic exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes (2004) 64th American Diabetes Association Congress, , Late-breaking abstract presented, Orlando, June 4-8
Nielsen, L.L., Young, A.A., Parkes, D.G., Pharmacology of exenatide (synthetic exendin-4): A potential therapeutic for improved glycemic control, of type 2 diabetes (2004) Regul Pept, 117, pp. 77-88
Fineman, M.S., Bicsak, T.A., Shen, L.Z., Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes (2003) Diabetes Care, 26, pp. 2370-2377
Kolterman, O.G., Buse, J.B., Fineman, M.S., Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes (2003) J Clin Endocrinol Metab, 88, pp. 3082-3089
Scheen, A.J., Interruption prématurée des études ASCOT et CARDS de prévention cardio-vasculaire avec l'atorvastatine chez le sujet hypertendu ou diabétique: Compromis entre éthique et statistique en médecine factuelle (2003) Rev Med Liège, 58, pp. 585-590
Colhoun, H.M., Thomason, M.J., Mackness, M.I., Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes (2002) Diabet Med, 9, pp. 201-211
Colhoun, H.M., Betteridge, J., Durrington, P.N., The Collaborative Atorvastatin Diabetes Study (CARDS) effectiveness of lipid lowering for the primary prevention of major cardiovascular events in diabetes (2004) 64th American Diabetes Association Congress, , Late-breaking abstract presented at the, Orlando, June 4-8
Scheen, A.J., Kulbertus, H., "REVERSAL" et "PROVEIT": Confirmation du concept «the lower, the better» dans le traitement de l'hypercholesté rolémie chez le patient coronarien (2004) Rev Med Liège, 59, pp. 167-173
Paquot, N., Scheen, A.J., Prévention cardio-vasculaire chez le patient diabétique de type 2 (2003) Rev Med Liège, 58, pp. 271-227
Gotto, A.M., Lipid management in diabetic patients: Lessons from prevention trials (2002) Am J Med, 112 (SUPPL. 8A), pp. 19S-26S
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial (2003) Lancet, 361, pp. 2005-2016
DeBacker, G., Ambrosioni, E., Borch-Johnsen, K., Executive summary. European guidelines on cardiovascular disease prevention in clinical practice (2003) Eur Heart J, 24, pp. 1600-1609. , Third Joint Task Force of European and other Societies on cardiovascular disease prevention in clinical practice
